Monday, February 02, 2026 | 01:06 PM ISTहिंदी में पढें
Bliss GVS Pharma Ltd
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
06:44 PM, 27th Jan 2026
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we would like to inform you that Bliss GVS International PTE Ltd. Singapore a wholly owned subsidiary of Bliss GVS Pharma Limited has incorporated a wholly-owned subsidiary namely Theralife Pharma RDC Private Limited Kinshasa Gombe Democratic Republic of the Congo.